Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Archives of Neurology
|
October 28, 1997
Gut response. Therapy with ingested immunomodulatory proteins
S A Brod
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
September 7, 1999
Autoimmunity is a type I interferon-deficiency syndrome corrected by ingested type I IFN via the GALT system
S A Brod
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
December 29, 2000
Unregulated inflammation shortens human functional longevity
S A Brod
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
August 26, 1998
Hypothesis: multiple sclerosis is a type I interferon deficiency syndrome
S A Brod
Journal of Autoimmunity
|
February 1, 1996
Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis
S A Brod, M Khan
Autoimmunity
|
January 1, 1994
Defective CD3 mediated proliferation and LPS responsiveness in multiple sclerosis
S A Brod, M Scott
Neurology
|
June 1, 1994
Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons
S A Brod, D K Burns
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1991
Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease
S A Brod, D Benjamin, D A Hafler
Annals of Neurology
|
January 13, 2000
Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis
S A Brod, J W Lindsey, J S Wolinsky
American Family Physician
|
September 15, 1996
Multiple sclerosis: clinical presentation, diagnosis and treatment
S A Brod, J W Lindsey, J S Wolinsky
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Archives of Neurology
|
October 28, 1997
Gut response. Therapy with ingested immunomodulatory proteins
S A Brod
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
September 7, 1999
Autoimmunity is a type I interferon-deficiency syndrome corrected by ingested type I IFN via the GALT system
S A Brod
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
December 29, 2000
Unregulated inflammation shortens human functional longevity
S A Brod
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
August 26, 1998
Hypothesis: multiple sclerosis is a type I interferon deficiency syndrome
S A Brod
Journal of Autoimmunity
|
February 1, 1996
Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis
S A Brod, M Khan
Autoimmunity
|
January 1, 1994
Defective CD3 mediated proliferation and LPS responsiveness in multiple sclerosis
S A Brod, M Scott
Neurology
|
June 1, 1994
Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons
S A Brod, D K Burns
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1991
Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease
S A Brod, D Benjamin, D A Hafler
Annals of Neurology
|
January 13, 2000
Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis
S A Brod, J W Lindsey, J S Wolinsky
American Family Physician
|
September 15, 1996
Multiple sclerosis: clinical presentation, diagnosis and treatment
S A Brod, J W Lindsey, J S Wolinsky
Page
of 4